Feasibility
Studies currently in Feasibility
Embedded Files
Last content update -Â 22nd September 2025
Please contact the Cancer Research Team for more information
All Specialties
No trials currently in feasibility
No trials currently in feasibility
BLADDER
No trials currently in feasibility
No trials currently in feasibility
BREAST
No trials currently in feasibility
No trials currently in feasibility
COLORECTAL
No trials currently in feasibility
No trials currently in feasibility
GYNAE
MK2870-022
MK2870-022
Specialty: Gynae
PI: Prof. Dennis Hadjiyiannakis
CPMS No: 368839
Estimated Opening: December 2025
Description: A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment With or Without Bevacizumab Versus Standard of Care After Second-line Platinum-based Doublet Chemotherapy in Participants With Platinum-sensitive Recurrent Ovarian Cancer (TroFuse-022/ENGOT-ov84/GOG-3103)
Head & Neck
No trials currently in feasibility
No trials currently in feasibility
Lung
BNT327-03
BNT327-03
Specialty: Lung
PI: Dr Amin Ali
CPMS No: 64727
Estimated Opening: October / November 2025
Description: Safety and effectiveness of BNT327, an investigational therapy in combination with chemotherapy for patients with untreated small-cell lung cancer
Multiple Specialties
No trials currently in feasibility
No trials currently in feasibility
PROSTATE
ELIPSE
ELIPSE
Speciality: Prostate
PI: Mr Michal Smolski
CPMS No: 63289
Estimated Opening: TBC 2025 / 26
Description: A randomised controlled trial comparing the clinical and cost-effectiveness of lymph node removal in patients undergoing curative surgery for localised high-risk Prostate Cancer.
RADIOTHERAPY
PROTIS
PROTIS
Specialty: Radiotherapy
PI: Mr Luigi Volpini
IRAS No: 325882
Estimated Opening: TBC 2025
Description: A phase III trial of proton beam therapy versus intensity-modulated radiotherapy for the treatment of sinonasal malignancy
RENAL
No trials currently in feasibility
No trials currently in feasibility
SKIN
NuTide:701
NuTide:701
Specialty: Skin
PI: Prof. Ruth Board
CPMS: 39985
Estimated Opening: November / December 2025
Description: A Phase I/II, open-label, dose-escalation and expansion study to assess the safety, pharmacokinetics and clinical activity of NUC 7738, a nucleotide analogue, in patients with advanced solid tumours and lymphoma
Supportive and Palliative Care
No trials currently in feasibility
No trials currently in feasibility
Teens & Young Adults (TYA)
No trials currently in feasibility
No trials currently in feasibility
UPPER GI
Protieus
Protieus
Specialty: Upper GI
PI: Dr Catherine Mitchell
IRAS: 329646
Estimated Opening: TBC 2025 / 26
Description: A Randomised Phase 2 Trial Comparing Proton versus Photon Based Neoadjuvant Chemoradiation, followed by Adjuvant Immunotherapy, in Oesophageal Cancer.
Report abuse